AA
AGTC

ALPS Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

ALPS Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,995
Closed -$225K – 741
2016
Q3 		$225K Sell
22,995
-2,344
-9% -$31.6K ﹤0.01% 652
2016
Q2 		$358K Buy
25,339
+5,054
+25% +$78.8K ﹤0.01% 534
2016
Q1 		$284K Sell
20,285
-3,432
-14% -$50.3K ﹤0.01% 581
2015
Q4 		$484K Sell
23,717
-2,094
-8% -$32.3K ﹤0.01% 487
2015
Q3 		$3.39K Buy
25,811
+9,512
+58% +$158K ﹤0.01% 642
2015
Q2 		$250K Buy
+16,299
New +$313K ﹤0.01% 667

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ALPS Advisors's AGTC Position: Q4 2016 in Review

ALPS Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2016, closing a stake of 22,995 shares — an estimated $225K sold.

ALPS Advisors first reported a position in AGTC in Q2 2015 and held it in 6 quarters. The position peaked at $484K in Q4 2015. 90 funds tracked by Wall St. Rank hold AGTC as of Q4 2016.

  • ALPS Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q4 2016 after selling out during the quarter.
  • ALPS Advisors sold 22,995 Applied Genetic Technologies Corporation shares in Q4 2016, an estimated $225K.
  • ALPS Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 6 quarters.
  • ALPS Advisors's Applied Genetic Technologies Corporation position peaked at $484K in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2016.

Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.